SEARCH

SEARCH BY CITATION

References

  • Aranha, F.J., Vigorito, A.C., De Sousa, C.A., Oliveira, G.B., Zulli, R. & Lorand-Metze, I. (2002) The influence of the graft monocytes in the outcome of allogeneic bone marrow transplantation. Haematologica, 87, 219220.
  • Berenson, R.J., Shpall, E.J., Auditore-Hargreaves, K., Heimfeld, S., Jacobs, C. & Krieger, M.S. (1996) Transplantation of CD34+ hematopoietic progenitor cells. Cancer Investigation, 14, 589596.
  • Bryson, J.S., Jennings, C.D., Caywood, B.E., Dix, A.R., Lowery, D.M. & Kaplan, A.M. (1997) Enhanced graft-versus-host disease in older recipient mice following allogeneic bone marrow transplantation. Bone Marrow Transplantation, 19, 721728.
  • Cetkovic-Cvrlje, M. & Tibbles, H.E. (2004) Therapeutic potential of Janus kinase 3 (JAK3) inhibitors. Current Pharmaceutical Design, 10, 176184.
  • Cetkovic-Cvrlje, M. & Uckun, F.M. (2004) Targeting Janus kinase 3 in the treatment of leukemia and inflammatory diseases. Archivum immunologiae et therapiae experimentalis, 52, 6982.
  • Cetkovic-Cvrlje, M., Roers, B.A., Waurzyniak, B., Liu, X.P. & Uckun, F.M. (2001) Targeting Janus Kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice. Blood, 98, 16071613.
  • Cetkovic-Cvrlje, M., Roers, B.A., Schonhoff, D., Waurzyniak, B., Liu, X.P. & Uckun, F.M. (2002) Treatment of post-bone marrow transplant acute graft-versus-host disease with a rationally designed JAK3 inhibitor. Leukemia and Lymphoma, 43, 14471553.
  • Ferrara, J.L. (2003) The pathophysiology of acute graft-versus-host disease. International Journal of Hematology, 78, 181187.
  • Horwood, N.J., Mahon, T., McDaid, J.P., Campbell, J., Mano, H., Brennan, F.M., Webster, D. & Foxwell, B.M. (2003) Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production. Journal of Experimental Medicine, 197, 16031611.
  • Koh, C.Y., Welniak, L.A. & Murphy, W.J. (2000) Adoptive cellular immunotherapy: NK cells and bone marrow transplantation. Histology and Histopathology, 15, 12011210.
  • Kurosaki, T. (2000) Functional dissection of BCR signaling pathways. Current Opinion in Immunology, 12, 276281.
  • Mahajan, S., Ghosh, S., Sudbeck, E.A., Zheng, Y., Downs, S., Hupke, M. & Uckun, F.M. (1999) Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl) propenamide]. Journal of Biological Chemistry, 274, 95879599.
  • Mano, H. (1999) The Tec family protein-tyrosine kinases: a subset of kinases for a subset of signalings. International Journal of Hematology, 69, 612.
  • Marmont, A.M., Horowitz, M., Gale, R., Sobocinski, K., Ash, R., van Bekkum, D., Champlin, R., Dicke, K., Goldman, J., Good, R., Herzig, R., Hong, R., Masaoka, T., Rimm, A., Ringden, O., Speck, B., Weiner, R. & Bortin, M. (1991) T cell depletion of HLA-identical transplants in leukemia. Blood, 78, 21202130.
  • Martin, P.J., Hansen, J.A., Torok-Storb, B., Durnam, D., Przepiorka, D., O'Quigley, J., Sanders, J., Sullivan, K.M., Witherspoon, R.P., Deeg, H.J., Appelbaum, F.R., Stewart, P., Weiden, P., Doney, K., Buckner, C.D., Clift, R., Storb, R. & Thomas, E.D. (1988) Graft failure in patients receiving T-cell depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplantation, 3, 445456.
  • Mielcarek, M., Martin, P.J. & Torok-Storb, B. (1997) Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood, 89, 16291634.
  • Mukhopadhyay, S., George, A., Bal, V., Ravindran, B. & Rath, S. (1999) Bruton's tyrosine kinase deficiency in macrophages inhibits nitric oxide generation leading to enhancement of IL-12 induction. Journal of Immunology, 163, 17861792.
  • Mukhopadhyay, S., Mohanty, M., Mangla, A., George, A., Bal, V., Rath, S. & Ravindran, B. (2002) Macrophage effector functions controlled by Bruton's tyrosine kinase are more crucial than the cytokine balance of T cell responses for microfilarial clearance. Journal of Immunology, 168, 29142921.
  • O'Reilly, R.J. (1983) Allogeneic bone marrow transplantation: current status and future directions. Blood, 62, 941964.
  • O'Reilly, R.J. & Papadopoulos, E.B. (1997) Allogeneic Transplantation. William and Wilkins, Baltimore.
  • Poynton, C. (1988) T cell depletion in bone marrow transplantation. Bone Marrow Transplantation, 3, 265279.
  • Rao, A.R., Quinones, M.P., Garavito, E., Kalkonde, Y., Jimenez, F., Gibbons, C., Perez, J., Melby, P., Kuziel, W., Reddick, R.L., Ahuja, S.K. & Ahuja, S.S. (2003) CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease. Journal of Immunology, 171, 48754885.
  • Rawlings, D.J. & Witte, O.N. (1994) Bruton's tyrosine kinase is a key regulator in B-cell development. Immunological Reviews, 138, 105119.
  • Smith, C.I., Baskin, B., Humire-Greiff, P., Zhou, J.N., Olsson, P.G., Maniar, H.S., Kjellen, P., Lambris, J.D., Christensson, B., Hammarstrom, L. Bentley D, Vetrie D, Islam KB, Vorechovsky I, Sideras P. (1994) Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. Journal of Immunology, 152, 557565.
  • Sprent, J., Schaefer, M. & Korngold, R. (1990) Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD. Journal of Immunology, 144, 29462954.
  • Sprent, J., Hurd, M., Schaefer, M. & Heath, W. (1995) Split tolerance in spleen chimeras. Journal of Immunology, 154, 11981206.
  • Steller, H. (1995) Mechanisms and genes of cellular suicide. Science, 267, 14451449.
  • Sudbeck, E.A., Liu, X.-P., Narla, R.K., Mahajan, S., Ghosh, S., Mao, C. & Uckun, F.M. (1999) Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing anti-leukemic agents. Clinical Cancer Research, 5, 15691582.
  • Tanaka, J., Imamura, M., Kasai, M., Asaka, M. & Torok-Storb, B. (1999) The role of accessory cells in allogeneic peripheral blood stem cell transplantation. International Journal of Hematology, 69, 7074.
  • Uckun, F.M. (1998) Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosis. Biochemical Pharmacology, 56, 683691.
  • Uckun, F.M. & Zheng, Y. (2000) BTK inhibitors and methods for their identification and use. United States Government Printing Office, Washington, DC.
  • Uckun, F.M. & Zheng, Y. (2001) BTK Inhibitors and Methods for their Identification and Use. United States Government Printing Office, Washington, DC.
  • Uckun, F.M., Roers, B.A., Waurzyniak, B. & Cetkovic-Cvrlje, M. (2002a) Janus kinase 3 inhibitor WHI-P131/JANEX-1 prevents graft-versus-host disease but spares the graft-versus-leukemia function of the bone marrow allografts in a murine bone marrow transplantation model. Blood, 99, 41924199.
  • Uckun, F.M., Zheng, Y., Cetkovic-Cvrlje, M., Vassilev, A., Lisowski, E., Waurzyniak, B., Chen, H., Carpenter, R. & Chen, C.L. (2002b) In vivo pharmacokinetic features, toxicity profile, and chemosensitizing activity of alpha-cyano-beta-hydroxy-beta- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a novel antileukemic agent targeting Bruton's tyrosine kinase. Clinical Cancer Research, 8, 12241233.
  • Vassilev, A., Ozer, Z., Navara, C., Mahajan, S. & Uckun, F.M. (1999) Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex. Journal of Biological Chemistry, 274, 16461656.